Practical steps to develop a transcriptomic test for blood doping

Blood doping remains a significant problem that threatens the integrity of sport. The current indirect method for detecting blood doping involves the longitudinal measurement of an athlete’s haematological variables and identification of suspicious results that are indicative of doping (i.e., the at...

Full description

Saved in:
Bibliographic Details
Published inTranslational Exercise Biomedicine Vol. 1; no. 2; pp. 105 - 110
Main Authors Sutehall, Shaun, Malinsky, Fernanda, Voss, Sven, Chester, Neil, Xu, Xiao, Pitsiladis, Yannis
Format Journal Article
LanguageEnglish
Published De Gruyter 04.09.2024
Subjects
anti-doping
blood doping
EPO
testing
transcriptomics
Online AccessGet full text

Cover

More Information
Summary:Blood doping remains a significant problem that threatens the integrity of sport. The current indirect method for detecting blood doping involves the longitudinal measurement of an athlete’s haematological variables and identification of suspicious results that are indicative of doping (i.e., the athlete biological passport). While this has played a significant role in the protection of clean sport, improvements are needed. The development of a transcriptomic test, that can be used to detect the use of blood doping has been discussed and researched for decades and yet, an anti-doping test that can be adopted by the World Anti-Doping Agency (WADA) is yet to be established. With recent advancements in our understanding, as well as in methods of sample collection, the possibility of a transcriptomic test that can be used by WADA, is imminent. There are, however, several practical considerations that must first be made, that will be highlighted in this perspective article.
ISSN:2942-6812
2942-6812
DOI:10.1515/teb-2024-0010